Decentralized regulation: What do FDA remote assessments mean for sponsors?

As Covid-19 enters an endemic stage, the FDA is poised to join the ranks of organizations establishing a hybrid approach to work. The agency is now combining traditional on-site visits with interactive virtual monitoring as part of a new remote regulatory assessment (RRA) program.